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Abstract
Exposure to environmental tobacco smoke (ETS) and active tobacco smoking has been shown to
increase symptoms of bronchial asthma such as bronchoconstriction but effects on other
respiratory symptoms remain poorly assessed. Current levels of exposure to tobacco smoke may
also be responsible for the development of chronic cough in both children and adults. The present
study analyses the effects of tobacco smoke exposure as potential causes of chronic cough. A panel
of PubMed-based searches was performed relating the symptom of cough to various forms of
tobacco smoke exposure. It was found that especially prenatal and postnatal exposures to ETS have
an important influence on children's respiratory health including the symptom of cough. These
effects may be prevented if children and pregnant women are protected from exposure to ETS.
Whereas the total number of studies adressing the relationship between cough and ETS exposure
is relatively small, the present study demonstrated that there is a critical amout of data pointing to
a causative role of environmental ETS exposure for the respiratory symptom of cough. Since
research efforts have only targeted this effect to a minor extent, future epidemiological and
experimental studies are needed to further unravel the relation between ETS and cough.
Introduction
Environmental tobacco smoke (ETS) or passive smoking,
has been demonstrated to be causally associated with a
large number of human diseases although the evidence is
sometimes conflicting and the tobacco industry has prob-
ably tried to cover up research data over the past 30 years
as suggested recently [1]. With regard to the different dis-
eases and symptoms associated with exposure to ETS, reli-
able evidence has been provided that exposure to ETS is
linked with impaired lung function and aggravation of
asthma in childhood and adulthood [2]. Asthmatic chil-
dren with mothers who smoke were found to have more
severe asthma when compared with children of non-
smoking mothers. Although, parental smoking has not
consistently been reported to correlate with the risk of
allergic sensitization in children, it has been suggested
Published: 2 May 2007
Cough 2007, 3:6 doi:10.1186/1745-9974-3-6
Received: 30 November 2006
Accepted: 2 May 2007
This article is available from: http://www.coughjournal.com/content/3/1/6
© 2007 Groneberg-Kloft et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Cough 2007, 3:6 http://www.coughjournal.com/content/3/1/6
Page 2 of 6
(page number not for citation purposes)
that maternal smoking during pregnancy or exposure of
children to ETS might lead to asthma via an increase of
bronchial hyperreactivity, increased sensitivity to aller-
gens, alterations in circadian variations of pulmonary
function, and irritant effects [3,4]. Together, these mecha-
nisms might be directly dependent on an increased
inflammatory burden of the upper and lower respiratory
tract due to an activation of neuroinflammatory reflexes,
recruitment of inflammatory cells, and proinflammatory
mediator release [5].
Whereas there seems to be a clear link between lung can-
cer and exposure to tobacco smoke [1], other respiratory
symptoms such as mucus secretion or chronic cough have
not been analysed in detail for the influence of tobacco
smoke exposure. The symptom of cough is one of the
most difficult respiratory symptoms to treat and only a lit-
tle is known about the exact mechanisms in children and
adults [6-8]. Pathophysiologically, coughing is coordi-
nated by neuronal reflexes in order to protect the respira-
tory tract from noxious exogenous substances such as
tobacco smoke or other factors [9-19] and numerous
complex mechanisms underlie this phenomenon [20-
24,24,25]. Recently, transient receptor potential vanil-
loid-1 has been suggested to play a major role in the
pathophysiology of the cough reflex [26,27] and numer-
ous research efforts have been undertaken to optimize the
diagnosis and treatment of the symptom [28-35].
Whereas exposure to ETS has been demonstrated to be
associated with the occurrence of numerous pathological
conditions, the link between ETS and the symptom of
cough has not been analysed in great detail so far. There-
fore, the present study aimed to analyse the association of
ETS and cough on the basis of database searches and exist-
ing clinical and experimtenal studies [36-43,20,44-58].
Methods
Database searches were conducted using terms including
"cough", "environmental", and various other terms
related to tobacco smoke exposure. (date: 2006-03-03).
The PubMed system was used. This is a service of the U.S.
National Library of Medicine. It includes over 16 million
citations from MEDLINE and other life science journals
for biomedical articles back to the 1950s. PubMed
includes links to full text articles and other related
resources [59].
To further delineate the impact of research focussed on
the symptom cough and its relation to tobacco smoke, all
publication years dating back to 1969 were screened. The
number of entries related to the terms tobacco and cough
were assessed. Also, the different publication dates of the
articles were analysed. Finally, articles were screened for
their contents and relevant data was analysed.
Results and Discussion
Frequency of research related to cough and tobacco smoke 
exposure
For the terms "cough" and "environment" a total of 984
entries were found in PubMed. While 370 entries con-
tained the terms "cough" and "smoke" (Fig. 1), 306
entries contained "cough" and "tobacco" and 298 entries
"cough" and "cigarette". Narrowing the research to ETS by
using the terms "cough" and "environmental tobacco
smoke" only 59 entries were found, suggesting that the
relation of the symptom cough to ETS has not been
focussed on in detail over the past few years. To further
analyse the distribution of studies addressing cough and
its relation to tobacco smoke, different publication dates
were screened and a differential distribution was found.
In this respect, an increasing frequency was found begin-
ning from the year 1969 with one article increasing to 21
articles in the year 2005 (Fig. 2).
Environmental tobacco smoke
There has been increasing evidence that the exposure of
adults and children to environmental tobacco smoke
(ETS) is a general health hazard and exerts major deleteri-
ous effects on the cardio-respiratory system [2,36,60-
65,4,66]. In this respect, significant associations have
been found between ETS for respiratory diseases such as
adult and pediatric asthma. Also a series of epidemiologi-
cal analyses on parental smoking and respiratory health in
children have been performed [60,64,65,4,66-71]. Over-
all there was a very consistent picture with odds ratios for
respiratory illnesses and symptoms between 1.2 and 1.6
for either parent smoking, the odds usually being higher
in pre-school than in school aged children. For cough, the
PubMed search for the terms cough and tobacco smoke  exposure Figure 1
PubMed search for the terms cough and tobacco smoke 
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odds ratio when both parents were smokers was 1.67
(1.48 to 1.89) [67-71].
To assess the number of studies linking cough and
tobacco smoke exposure, different search terms were used
and it was found that while there was a relatively high
number of studies with both the terms "cough" and
"smoke" (370 entries) or "cough and tobacco (306
entries), only 59 studies had both the terms "cough" and
"environmental tobacco smoke".
Important methodological issues arise in the assessment
of associations between ETS exposure and respiratory dis-
eases such as chronic cough, as there is the possibility of
confounding by variables related both to the exposure
and the outcome of interest [60]. By analyzing available
data self-reported health conditions such as chronic
cough can be related to ETS exposure in men (Table 1)
and women (Table 1) who were never smokers of any
tobacco products. Significant values were found for the
association of chronic cough to heavy (> 40 hours/week)
ETS exposure at home in men, for the association of
chronic cough to heavy (> 40 hours/week) ETS exposure
in small spaces, total ETS exposure, and large indoor areas
in men. For women, significant values were found for
heavy ETS exposure in small spaces and in large indoor
areas and for total ETS exposure [60].
Other data describing the effects of ETS often used non-
smoking wives and smoking discordant husbands. Here,
it was also shown that wives with never-smoked husbands
had lower frequencies of chronic cough, next to a better
socio-economic status and better indices of the family
cohesiveness. These differences were largest when com-
paring wives of never-smoked vs. heavily smoking hus-
bands (more than 20 cigarettes/day), suggesting a dose-
response [72].
The association between the smoking status and the prev-
alence of chronic cough was also analyzed in the long-
term ambient air pollution and respiratory symptoms in
adults study (SAPALDIA) [73]. This cross-sectional study
in random population samples of adults in Switzerland
reported prevalences of chronic cough in percent by
smoking status and found 3.3 (2.8 – 3.8, 95% confidence
interval) of never smokers (n = 4.229), 3.0 (2.3 – 3.7) of
former smokers (n = 2.175) and 9.2 (8.2 – 10.2) of cur-
rent smokers (n = 3.232) [73].
ETS exposure has been shown to increase symptoms of
allergic bronchial asthma, but direct effects on the expres-
sion of inflammatory markers have not been analysed in
detail previously. Therefore, a recent study assessed the
correlation of ETS exposure with the expression of inflam-
matory mediators in airway secretions of children with
asthma. IFN-gamma and IL-12, as well as IL-5 and IL-13
Table 1: Association between ETS exposure abd self-reported chronic cough in man.
ETS exposure (hours/week)
n = 514 male Odds ratio (95% CI)
0 1–9 10–39 >40 Heavy vs. no exposure Any vs. no exposure
at home 3.0 2.9 4.3 4.3** 1.33 (0.80, 2.08) 1.11 (0.89, 1.38)
Small spaces 2.8 3.2 3.4 4.7*** 1.72 (1.23, 2.36) 1.25 (1.04, 1.05)
Large indoor areas 2.8 3.1 4.2 3.7* 1.26 (0.78, 1.94) 1.20 (0.99, 1.45)
Total exposure 2.7 2.9 3.3 4.4*** 1.60 (1.22, 2.10) 1.22 (1.00, 1.49)
Entries were age-adjusted per 100 individuals by level of ETS exposure. * linear trend < 0.05, ** < 0.005, < 0.0001. Odds ratios were adjusted for 
age, alcohol consumption, body mass index, diabetes, ethnicity, education status, hypertension, marital status, physical activity at work, serum total 
cholesterol, and individual occupational hazards. Standard deviation (SD) for home exposure = 19.9 hours/week; SD for small spaces exposure = 
15.5 hours/week; SD for large indoor areas exposure = 13.4 hours/week; SD for total exposure = 24.7 hours/week. Modified from [60].
PubMed search for the terms cough and tobacco and publica- tion dates Figure 2
PubMed search for the terms cough and tobacco and publica-
tion dates. An exponential trendline indicates the increase 
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were analysed in allergic asthmatic children and healthy
children [74]. Using nasopharyngeal aspiration, airway
secretions were collected from 24 atopic children with
asthma (age, 6–16 years) and 26 healthy control subjects,
and cytokine concentration was determined by means of
immunoenzymatic methods. It was shown that IL-13 lev-
els were highly increased in patients with asthma (P <
.005). Also, a positive correlation between IL-13 levels
and serum IgE concentrations (r(s) = 0.55) was found in
children with allergic asthma. Parental tobacco smoking
lead to a significant increase in airway IL-13 secretion
compared with nonexposed children and healthy control
subjects (median, 860 pg/mL vs 242 pg/mL and 125 pg/
mL, respectively) [74]. Together, these results indicate that
ETS exposure augments the expression and secretion of IL-
13 in allergic asthma. Measurements of IL-13 in secretions
might be taken into account as a noninvasive marker of
airway inflammation and to assess the detrimental effects
of ETS.
Regarding the mechanisms between smoke exposure and
chronic cough, recent studies have assessed capsaicin
responsiveness [75-77]. It was shown that cough reflex
sensitivity is enhanced soon after smoking cessation.
Therefore, it was suggested that diminished cough sensi-
tivity in smokers results from chronic cigarette smoke-
induced desensitization of airway cough receptors. In a
further study, the cough reflex sensitivity to capsaicin
(C(5)) was evaluated in 11 chronic smokers who had dis-
continued smoking for at least 2 weeks, and then resumed
smoking. It was shown that two weeks after smoking ces-
sation there was a significant enhancement of cough reflex
sensitivity; mean (+/-SEM) log C(5) decreased from
1.77+/-0.18 to 1.47+/-0.14 (p = 0.01). The subjects
resumed smoking after 2–12 weeks of abstinence and a
repeat capsaicin cough challenge was performed 14–23
days after resumption of smoking. The mean log C(5)
increased compared to the last value obtained during the
smoking cessation period (1.42+/-0.15 vs. 1.77+/-0.16, p
= 0.0004) and the mean log C(5) after resumption of
smoking returned to almost exactly the baseline value.
These data point to a dynamic phenomenon in the sensi-
tivity of airway cough receptors. In this respect, they seem
to be promptly affected and modulated by the presence or
absence of cigarette smoke [77]. Similar results were dem-
onstrated in experimental animal models of passive ETS
exposure [78].
The different reports clearly indicate an association
between ETS and chronic cough. Whereas active tobacco
smoking is without a doubt related to chronic cough and
other more prominent diseases such as bronchial carci-
noma, passive ETS may also be a relevant risk factor for
chronic cough [36]. The present analysis concerns envi-
ronmental exposure to tobacco smoke. In this respect, it
neglects chronic cough in active tobacco smokers. Issues
related to active smoking that need to be analysed in the
future are the association of active tobacco smoking on
the symptom of chronic cough. This is of major interest
because it needs to be determined whether cough or spu-
tum production are predictors of COPD. This association
may also be assessed by studies that focus at symptom
modification after smoking cessation. It will also be
important to address whether it is the active exposure or
the resulting damage that is causing cough in chronic
tobacco smokers.
Suspended particulate matter
A further important environmental factor contributing to
chronic cough is displayed by suspended particulate mat-
ter (SPM) [36] and tobacco smoke products also belong to
SPM fractions. 6 entries in the PubMed were found that
linked cough to the term "particulate". Effects of SPM crit-
ically depend on the particle size and the concentration
and may fluctuate with daily fluctuations in the PM10 or
PM2.5 levels. The actual relationship between PM10 or
PM2.5 exposure and health effects has been shown to be
linear at concentrations below 100 micrograms/m3 and
Table 2: Association between ETS exposure abd self-reported chronic cough in women.
ETS exposure (hours/week)
n = 808 female Odds ratio (95% CI)
0 1–9 10–39 >40 Heavy vs. no exposure Any vs. no exposure
at home 2.9 3.2 4.2 3.0 0.93 (0.65, 1.28) 1.14 (0.97, 1.34)
Small spaces 2.8 3.2 4.1 3.4* 1.17 (0.89, 1.51) 1.17 (1.01, 1.37)
Large indoor areas 2.9 3.1 3.6 5.1*** 1.68 (1.17, 2.34) 1.12 (0.96, 1.30)
Total exposure 2.7 2.8 3.8 3.3** 1.14 (0.92, 1.42) 1.12 (0.96, 1.32)
Entries were age-adjusted per 100 individuals by level of ETS exposure. * linear trend < 0.05, ** < 0.005, < 0.0001. Odds ratios were adjusted for 
age, alcohol consumption, body mass index, diabetes, ethnicity, education status, hypertension, marital status, physical activity at work, serum total 
cholesterol, and individual occupational hazards. Standard deviation (SD) for home exposure = 19.9 hours/week; SD for small spaces exposure = 
15.5 hours/week; SD for large indoor areas exposure = 13.4 hours/week; SD for total exposure = 24.7 hours/week. Modified from [60].Cough 2007, 3:6 http://www.coughjournal.com/content/3/1/6
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currently there are no threshold known below which no
effects occur. Large variance in short-term health effects
have been reported which may base on the influence of
concomitant gaseous pollutants.
A study on the association between the indoor PM10 and
chronic cough in 3,709 Chinese adults demonstrated
highly significant differences between study areas in the
prevalence of chronic cough. Median indoor concentra-
tions of PM10 were much higher in Beijing (557 micro-
grams/m3), where the highest prevalence for chronic
cough was also found [79].
In the Swiss SCARPOL study, reported symptom rates of
chronic cough, nocturnal dry cough, and bronchitis,
adjusted for individual risk factors, were positively associ-
ated with PM10, NO2, and SO2. In this study, the strong-
est relationship was observed for PM10 (adjusted odds
ratio) between the most and the least polluted commu-
nity with a value of 3.07 (95% CI: 1.62 to 5.81) for
chronic cough [80].
Concerning ambient air pollution, a comparison of non-
smoking residents of lower- and higher-pollution zones,
which were stratified according to socioeconomic levels
and sex, showed that chronic cough but not wheeze was
significantly more common in the higher-pollution zone
in only some of the strata [81].
Conclusion
Environmental tobacco smoke exposure does not only
lead to lung cancer and cardiorespiratory disease but is
also related to numerous respiratory symptoms. Whereas
it has been known for a long time that exacerbations of
bronchial asthma and chronic obstructive pulmonary dis-
ease might be aggravated by ETS exposure, only little
knowledge has been accumulated concerning the relation
of ETS and symptoms such as cough. The present study
assessed this relation by analyzing the existing literature.
The results clearly indicate that ETS exposure may lead to
the symptom of cough. Since only a few experimental
approaches exist to date to treat cough, further studies on
the clinical, experimental and molecular basis are needed.
These studies should analyze the pathophysioloical basis
and identify genetic factors of chronic cough. Also, new
options to treat this respiratory condition need to be eval-
uated.
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